(PDF) A reflection on HIV/AIDS research after 25 years
(PDF) The impact of HIV and AIDS research: a case study from Swaziland
Groundbreaking HIV Research: Leading to the Cure
COMMENTS
HIV Faculty Researchers, A-L
Jason Farley, PhD, MPH, NP, Associate Professor, Johns Hopkins School of Nursing, research seeks to optimize the prevention and management of HIV infection with a particular emphasis on drug-resistant tuberculosis among persons with HIV in international settings. He is the Director, PhD Program / REACH Initiative; Co-Director Clinical Core ...
Trevor A. Crowell, M.D., Ph.D
Dr. Crowell is the Director of the Clinical Research Directorate at MHRP, where he oversees cohorts and other epidemiologic studies of HIV, sexually transmitted infections, and other infectious disease threats to global public health and U.S. military force readiness. Dr. Crowell is a physician specialist in infectious diseases who received his ...
Nelson L. Michael, M.D., Ph.D.
Nelson L. Michael, M.D., Ph.D., is the Director of the Center for Infectious Diseases Research. Dr. Michael graduated summa cum laude from the University of California, Los Angeles in 1979 with a degree in biology and from Stanford University with and M.D. and Ph.D. (cancer biology) degrees in 1986. He trained in internal medicine at Harvard ...
Jeffrey Wickersham, PhD < C. Shan Xu Lab
Active Research. Integrated online-to-offline (O2O) model of care for HIV prevention and treatment among men who have sex with men. Grant No: R34 MH128114-01A1; Online HIV self-testing (HIVST) with virtual e-counseling provides an innovative approach to improving and retaining individuals in regular HIV testing.
Harvard University
The Harvard University Center for AIDS Research (HU CFAR) provides research, education and training opportunities to HIV researchers across Harvard University and its affiliates through services that are in direct response to the needs of the community.
hiv PhD Projects, Programmes & Scholarships
Funded PhD- Physiology and therapeutic modulation of oxidative phosphorylation in HIV-1 infected cells. University of Bristol School of Cellular and Molecular Medicine. Applications for this funded project will be reviewed on a rolling basis until the position is filled. Please apply as soon as possible.
Morgane Rolland, Ph.D.
Research Dr. Rolland is interested in better understanding the infectious disease dynamics of emerging human viral pathogens, in particular HIV-1, and translating this knowledge to develop vaccines. The Rolland Lab generates and analyzes molecular sequence data to infer evolutionary and population dynamic processes, while also integrating ...
Research priorities for an HIV cure: International AIDS ...
An effective and scalable cure strategy is a top priority for the HIV research field; this Review discusses recent advances, knowledge gaps, and priority research areas for the next 5 years.
Some of the Many Faces of HIV Research: Treatment, Prevention and
Following is a broad look at some of our work in HIV research. Searching for a cure. Nancy Archin, PhD, is using single cell and spatial transcriptomics to better define the sources of persistent and latent HIV infection in gut tissues of both men and women. This includes assessing whether sex differences contribute to HIV persistence in ...
HIV
The Ragon's first research priority area was HIV, a devastating epidemic affecting millions of people worldwide. Our goal is to eradicate HIV by working collaboratively with scientists and affected communities in South Africa, the epicenter of the HIV epidemic. At the Ragon, engineers, immunologists, clinicians, computational biologists, and immunogeneticists work together to integrate key ...
Disease Research
Dr. Khoshnood's research interests include: 1) epidemiology and prevention of HIV/AIDS, 2) research ethics and 3) humanitarian health. Linda Niccolai is the Associate Dean for Academic Affairs at Yale School of Public Health and Professor in the Department of Epidemiology of Microbial Diseases.
HIV/AIDS Research: Department of Medicine: Feinberg School of Medicine
Clinical HIV research in the Division of Infectious Diseases is largely conducted through the A IDS Clinical Trials Group (ACTG), which has been funded by the National Institute of Allergy and Infectious Diseases since 1987. The ACTG is the largest network of expert clinical and translational investigators and therapeutic clinical trials units in the world, including sites in low- and middle ...
hiv aids PhD Projects, Programmes & Scholarships
University of Bristol Bristol Medical School. In Europe and North America, prognosis for persons with HIV (PWHIV) has improved since the introduction of combined antiretroviral in 1996 [1]. Read more. Supervisor: Dr SI Ingle. Year round applications PhD Research Project Self-Funded PhD Students Only. More Details.
Researchers interested in HIV/AIDS
Raul U. Hernandez-Ramirez, PhD. Research Scientist in Biostatistics (CMIPS); Director, Dissemination and Implementation Science Methods (DISM) Core, Center for Interdisciplinary Research on AIDS; Affiliated Faculty, Yale Institute for Global Health.
Research Toward HIV Cure
Investing in research to find a cure for HIV is focused on two broad aims: sustained viral remission and, in the longer term, viral eradication. Viral latency and sanctuaries. Latent HIV reservoirs—small amounts of HIV that persist in people taking ART—present a significant challenge to finding a cure for HIV. Latent reservoirs remain in ...
Home page
Aims and scope. AIDS Research and Therapy publishes studies of basic, translational, clinical, epidemiological, behavioral and educational science addressing treatment and prevention of HIV/AIDS and associated conditions. This includes studies of disease pathogenesis, novel treatment strategies and the impacts of established treatment regimans.
HIV
HIV stands for human immunodeficiency virus. Like all viruses, it replicates itself inside the human body and spreads. But HIV is particularly notorious because it targets the immune system's master regulators, known as CD4 T-helper cells. These cells produce key signals that prompt other immune cells to swing into action - namely B-cells ...
Current Research
The HIV Center's research - conducted in New York City, New York State, and countries hardest hit by the HIV/AIDS epidemic - is focused on the following major areas: ... PhD. A Combination Intervention Strategy to Improve Health Outcomes for Adolescents Living with HIV in Mozambique (UG3HD096926) PI: Elaine Abrams, MD.
NIH HIV Research Program
The National Institutes of Health (NIH) provide a significant public investment in HIV/AIDS research. This investment requires substantial scientific coordination and management to avoid duplication and ensure research dollars are invested effectively across the NIH Institutes and Centers conducting HIV/AIDS research. This is the role of the Office of AIDS Research.
Matthew Romo, PharmD, PhD, MPH
He conducts research on HIV testing, prevention, treatment, and cure, and frequently leverages implementation science methodologies and frameworks. Matt is a registered pharmacist and doctoral-trained epidemiologist. He completed his PhD in epidemiology under the mentorship of Professor Denis Nash (Graduate School of Public Health and Health ...
Infectious Disease Epidemiology Research
She earned her PhD in microbiology and immunology from the University of Michigan in 2008. Dr. ... The HIV Cure Center research portfolio is focused on reactivation of the latent virus combined with clearance strategies to effectively purge the HIV reservoir to effect a cure for HIV. The HIV Cure Center has been at the forefront of HIV latency ...
Intramural AIDS Research Fellowship
This includes work in the following fields: epidemiology; etiology and pathogenesis; therapeutics research; vaccines; microbicides; health disparities; implementation sciences, and behavioral and social science research to address HIV infection and its associated coinfections, opportunistic infections, malignancies, and other complications.
NIH OAR 2023 Workshop for Early Career Investigators in HIV
Mallory Johnson, PhD, University of California, San Francisco. Mallory Johnson, PhD is a professor of medicine at USCF school of medicine and licensed clinical health psychologist, whose research has focused on understanding, measuring, and improving the health of patients with chronic diseases such as HIV. Dr. Johnson's program of multidisciplinary collaborative research is focused on ...
Current HIV Research
Research article Open access Effectors of Hyperlipidemia Among Patients with HIV/AIDS Taking Second-line Antiretroviral Therapy Based on Registry Data Chunling Yang, ...
Osman Wumpini Shamrock, PhD
Dr. Shamrock has a PhD from the College of Community and Public Affairs, Binghamton University. Shamrock focuses on understanding social and structural barriers to HIV prevention and care among transwomen of color. Specifically, Shamrock seeks to understand the experiences of trans women of color in HIV and sexual health services. He also seeks to
White House Seeking Community Input on 2026-2030 National HIV ...
A leading source of current and relevant information on Federal HIV policies, programs, resources, & science. Read about The National HIV/AIDS Strategy, our country's whole-of-society approach to end the HIV epidemic in the United States. Ending the HIV Epidemic in the U.S. is our nation's bold plan to end the HIV epidemic in the U.S. by 2030.
Understanding the lived experience research priorities for improving
Background: People living with HIV experience higher rates of cognitive impairment (CI), and at younger ages, than the general population. These individuals report poor health-related quality of life (HRQL), however, interventions aimed at assisting people living with HIV to live well with CI do not currently exist and represent an important un-met need in this population.
Landmark trial may herald new era in HIV prevention
New HIV infections have come down from more than 2 million globally in 2010 to 1.3 million last year. But a report released last week by the Joint United Nations Programme on HIV/AIDS (UNAIDS) shows progress has stalled, and the world seems likely to miss its target of just 370,000 infections by 2025.
Charting the Path to an HIV-Free Generation
NIAID supports four research networks as part of its HIV clinical research enterprise. Every seven years, the Institute engages research partners, community representatives, and other public health stakeholders in a multidisciplinary evaluation of network progress toward short- and long-term scientific goals. Pregnancy, childbirth and the postnatal period are a key focus of NIAID HIV research ...
Clinical Research
The Master of Science in Clinical Research program is designed for early-career health care professionals including physicians, dentists, pharmacists, and nurses. They will explore epidemiology and biostatistics, and learn about decision sciences, applied omics science, and translating innovation into clinical practice.
IMAGES
COMMENTS
Jason Farley, PhD, MPH, NP, Associate Professor, Johns Hopkins School of Nursing, research seeks to optimize the prevention and management of HIV infection with a particular emphasis on drug-resistant tuberculosis among persons with HIV in international settings. He is the Director, PhD Program / REACH Initiative; Co-Director Clinical Core ...
Dr. Crowell is the Director of the Clinical Research Directorate at MHRP, where he oversees cohorts and other epidemiologic studies of HIV, sexually transmitted infections, and other infectious disease threats to global public health and U.S. military force readiness. Dr. Crowell is a physician specialist in infectious diseases who received his ...
Nelson L. Michael, M.D., Ph.D., is the Director of the Center for Infectious Diseases Research. Dr. Michael graduated summa cum laude from the University of California, Los Angeles in 1979 with a degree in biology and from Stanford University with and M.D. and Ph.D. (cancer biology) degrees in 1986. He trained in internal medicine at Harvard ...
Active Research. Integrated online-to-offline (O2O) model of care for HIV prevention and treatment among men who have sex with men. Grant No: R34 MH128114-01A1; Online HIV self-testing (HIVST) with virtual e-counseling provides an innovative approach to improving and retaining individuals in regular HIV testing.
The Harvard University Center for AIDS Research (HU CFAR) provides research, education and training opportunities to HIV researchers across Harvard University and its affiliates through services that are in direct response to the needs of the community.
Funded PhD- Physiology and therapeutic modulation of oxidative phosphorylation in HIV-1 infected cells. University of Bristol School of Cellular and Molecular Medicine. Applications for this funded project will be reviewed on a rolling basis until the position is filled. Please apply as soon as possible.
Research Dr. Rolland is interested in better understanding the infectious disease dynamics of emerging human viral pathogens, in particular HIV-1, and translating this knowledge to develop vaccines. The Rolland Lab generates and analyzes molecular sequence data to infer evolutionary and population dynamic processes, while also integrating ...
An effective and scalable cure strategy is a top priority for the HIV research field; this Review discusses recent advances, knowledge gaps, and priority research areas for the next 5 years.
Following is a broad look at some of our work in HIV research. Searching for a cure. Nancy Archin, PhD, is using single cell and spatial transcriptomics to better define the sources of persistent and latent HIV infection in gut tissues of both men and women. This includes assessing whether sex differences contribute to HIV persistence in ...
The Ragon's first research priority area was HIV, a devastating epidemic affecting millions of people worldwide. Our goal is to eradicate HIV by working collaboratively with scientists and affected communities in South Africa, the epicenter of the HIV epidemic. At the Ragon, engineers, immunologists, clinicians, computational biologists, and immunogeneticists work together to integrate key ...
Dr. Khoshnood's research interests include: 1) epidemiology and prevention of HIV/AIDS, 2) research ethics and 3) humanitarian health. Linda Niccolai is the Associate Dean for Academic Affairs at Yale School of Public Health and Professor in the Department of Epidemiology of Microbial Diseases.
Clinical HIV research in the Division of Infectious Diseases is largely conducted through the A IDS Clinical Trials Group (ACTG), which has been funded by the National Institute of Allergy and Infectious Diseases since 1987. The ACTG is the largest network of expert clinical and translational investigators and therapeutic clinical trials units in the world, including sites in low- and middle ...
University of Bristol Bristol Medical School. In Europe and North America, prognosis for persons with HIV (PWHIV) has improved since the introduction of combined antiretroviral in 1996 [1]. Read more. Supervisor: Dr SI Ingle. Year round applications PhD Research Project Self-Funded PhD Students Only. More Details.
Raul U. Hernandez-Ramirez, PhD. Research Scientist in Biostatistics (CMIPS); Director, Dissemination and Implementation Science Methods (DISM) Core, Center for Interdisciplinary Research on AIDS; Affiliated Faculty, Yale Institute for Global Health.
Investing in research to find a cure for HIV is focused on two broad aims: sustained viral remission and, in the longer term, viral eradication. Viral latency and sanctuaries. Latent HIV reservoirs—small amounts of HIV that persist in people taking ART—present a significant challenge to finding a cure for HIV. Latent reservoirs remain in ...
Aims and scope. AIDS Research and Therapy publishes studies of basic, translational, clinical, epidemiological, behavioral and educational science addressing treatment and prevention of HIV/AIDS and associated conditions. This includes studies of disease pathogenesis, novel treatment strategies and the impacts of established treatment regimans.
HIV stands for human immunodeficiency virus. Like all viruses, it replicates itself inside the human body and spreads. But HIV is particularly notorious because it targets the immune system's master regulators, known as CD4 T-helper cells. These cells produce key signals that prompt other immune cells to swing into action - namely B-cells ...
The HIV Center's research - conducted in New York City, New York State, and countries hardest hit by the HIV/AIDS epidemic - is focused on the following major areas: ... PhD. A Combination Intervention Strategy to Improve Health Outcomes for Adolescents Living with HIV in Mozambique (UG3HD096926) PI: Elaine Abrams, MD.
The National Institutes of Health (NIH) provide a significant public investment in HIV/AIDS research. This investment requires substantial scientific coordination and management to avoid duplication and ensure research dollars are invested effectively across the NIH Institutes and Centers conducting HIV/AIDS research. This is the role of the Office of AIDS Research.
He conducts research on HIV testing, prevention, treatment, and cure, and frequently leverages implementation science methodologies and frameworks. Matt is a registered pharmacist and doctoral-trained epidemiologist. He completed his PhD in epidemiology under the mentorship of Professor Denis Nash (Graduate School of Public Health and Health ...
She earned her PhD in microbiology and immunology from the University of Michigan in 2008. Dr. ... The HIV Cure Center research portfolio is focused on reactivation of the latent virus combined with clearance strategies to effectively purge the HIV reservoir to effect a cure for HIV. The HIV Cure Center has been at the forefront of HIV latency ...
This includes work in the following fields: epidemiology; etiology and pathogenesis; therapeutics research; vaccines; microbicides; health disparities; implementation sciences, and behavioral and social science research to address HIV infection and its associated coinfections, opportunistic infections, malignancies, and other complications.
Mallory Johnson, PhD, University of California, San Francisco. Mallory Johnson, PhD is a professor of medicine at USCF school of medicine and licensed clinical health psychologist, whose research has focused on understanding, measuring, and improving the health of patients with chronic diseases such as HIV. Dr. Johnson's program of multidisciplinary collaborative research is focused on ...
Research article Open access Effectors of Hyperlipidemia Among Patients with HIV/AIDS Taking Second-line Antiretroviral Therapy Based on Registry Data Chunling Yang, ...
Dr. Shamrock has a PhD from the College of Community and Public Affairs, Binghamton University. Shamrock focuses on understanding social and structural barriers to HIV prevention and care among transwomen of color. Specifically, Shamrock seeks to understand the experiences of trans women of color in HIV and sexual health services. He also seeks to
A leading source of current and relevant information on Federal HIV policies, programs, resources, & science. Read about The National HIV/AIDS Strategy, our country's whole-of-society approach to end the HIV epidemic in the United States. Ending the HIV Epidemic in the U.S. is our nation's bold plan to end the HIV epidemic in the U.S. by 2030.
Background: People living with HIV experience higher rates of cognitive impairment (CI), and at younger ages, than the general population. These individuals report poor health-related quality of life (HRQL), however, interventions aimed at assisting people living with HIV to live well with CI do not currently exist and represent an important un-met need in this population.
New HIV infections have come down from more than 2 million globally in 2010 to 1.3 million last year. But a report released last week by the Joint United Nations Programme on HIV/AIDS (UNAIDS) shows progress has stalled, and the world seems likely to miss its target of just 370,000 infections by 2025.
NIAID supports four research networks as part of its HIV clinical research enterprise. Every seven years, the Institute engages research partners, community representatives, and other public health stakeholders in a multidisciplinary evaluation of network progress toward short- and long-term scientific goals. Pregnancy, childbirth and the postnatal period are a key focus of NIAID HIV research ...
The Master of Science in Clinical Research program is designed for early-career health care professionals including physicians, dentists, pharmacists, and nurses. They will explore epidemiology and biostatistics, and learn about decision sciences, applied omics science, and translating innovation into clinical practice.